Infinity Pharmaceuticals reported $45K in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US $ 328M 33M
Bristol Myers Squibb BMY:US $ 313M 13M
Cytori Therapeutics CYTX:US $ 181K 17K
Eli Lilly And LLY:US $ 81.2M 3.7M
Gilead Sciences GILD:US $ 242M 4M
Infinity Pharmaceuticals INFI:US $ 0.04M 0M
Novartis NOVN:VX 202M 1000K
Pfizer PFE:US $ 293M 29M
Tg Therapeutics TGTX:US $ 3.02M 0.35M
Vascular Biogenics VBLT:US 25K 15K
YTE INCY:US $ 0.68M 0M